From July 1, 2023 to October 9, 2023, the company has repurchased 30,000 shares, representing 0.005243% for CNY 0.49 million. With this, the company has completed the repurchase of 9,865,793 shares, representing 1.7% for CNY 200 million under the buyback announced on October 21, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20.16 CNY | +5.72% | +9.98% | +3.12% |
Feb. 29 | Sansure Biotech's 2023 Profit Drops 81% as Revenue Slumps 84% | MT |
Feb. 28 | Sansure Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.12% | 1.51B | |
+1.69% | 12.8B | |
-7.57% | 7.61B | |
+3.22% | 5.41B | |
+0.93% | 4.51B | |
+8.48% | 4.49B | |
+9.21% | 2.73B | |
-13.87% | 2.02B | |
-11.63% | 1.73B | |
+3.45% | 1.64B |
- Stock Market
- Equities
- 688289 Stock
- News Sansure Biotech Inc.
- Tranche Update on Sansure Biotech Inc.'s Equity Buyback Plan announced on October 21, 2022.